Saxenda® Lawsuit

Saxenda® lawsuits allege that the drug caused side effects like vision loss and stomach injuries. We’re here to help.

Developing a serious injury after taking Saxenda (liraglutide) for weight management could give you grounds to file a lawsuit and pursue compensation. People filing claims allege that Novo Nordisk failed to warn patients about possibly severe Saxenda side effects.

Get a free case review today to see if you qualify.

Get a Free Case Review
Published on:

Why Are People Filing Saxenda Lawsuits?

Many people have filed Saxenda claims after developing serious health problems, like sudden vision loss or stomach paralysis, while taking the drug. These injuries can affect your health, work, and family for years.

Saxenda contains liraglutide, a glucagon-like peptide-1 (GLP-1) drug made by Novo Nordisk. It’s approved to help adults and children ages 12 and older lose weight and keep it off. Some people also experience common side effects from their prescription, like diarrhea or heartburn.

However, Saxenda lawsuits claim that Novo Nordisk:

  • Didn’t warn patients and their health care providers about the drug’s full risks
  • Knew, or had reason to know, that Saxenda could cause vision loss or stomach injuries
  • Made false, misleading, or incomplete statements about the medication’s safety

People may be able to hold Novo Nordisk accountable through a medical product liability lawsuit. If your prescription caused Saxenda side effects that no one warned you about, our team is here to help.

Find out if you’re eligible for a Saxenda lawsuit today.

What Are the Side Effects of Saxenda?

Like other GLP-1 drugs, Saxenda commonly causes stomach-related symptoms. In clinical trials, nausea affected 39.3% of adults taking Saxenda, compared to 13.8% of people taking a placebo.

Constipation, headaches, and vomiting were also common, but these can be accompanied by more concerning symptoms in some cases.

Serious side effects from Saxenda named in lawsuits include:

  • Gallstones or gallbladder problems: Upper stomach pain, yellowing of the skin or eyes, clay-colored stool, or fever can be signs of a gallbladder problem.
  • Gastroparesis: Also called stomach paralysis, this condition slows or stops the movement of food from the stomach to the small intestine.
  • Ileus and bowel obstruction: These conditions keep food and waste from moving through the bowels with physical blockages. People in federal stomach injury lawsuits allege GLP-1 drugs caused them.
  • Non-arteritic anterior ischemic optic neuropathy (NAION): Reduced blood flow to the front of the optic nerve causes swelling and sudden vision loss.
  • Pancreatitis: Ongoing pain that begins in the upper left or middle of the stomach and that spreads to the back can be a sign of this serious condition.

If you’re living with any severe side effects of Saxenda, you deserve answers about your legal rights. You may be eligible for compensation that could help you pay for medical bills and other related costs.

Can Saxenda Affect Your Vision?

While Saxenda vision loss wasn’t reported in the drug’s clinical trials, the condition has been linked to other GLP-1 medications. Most research on GLP-1 drugs and loss of vision has focused on semaglutide, the active ingredient in Ozempic® and Wegovy®.

However, a 2026 study in Ophthalmology Retina found that people with type 2 diabetes who took liraglutide had a higher risk of NAION during their first 12 to 18 months of treatment than people taking certain other diabetes drugs.

Liraglutide-related NAION can change your life in an instant. According to the North American Neuro-Ophthalmology Society, there is no proven effective treatment for NAION, and about 15% of people with NAION in 1 eye develop it in the other eye within 5 years.

Sudden vision loss is a medical emergency. If you think you’re experiencing any Saxenda eye problems, get medical care right away. Then, you can talk with our team to learn about filing a medical product liability claim.

How Do You Qualify for a Saxenda Lawsuit?

We can help you find out whether you can move forward with a Saxenda lawsuit based on factors including your side effects and other case-specific details.

You may qualify for a liraglutide lawsuit if you:

  • Developed gastroparesis, an intestinal obstruction, NAION, or another serious side effect after starting your prescription
  • Needed hospital care or other medical treatment for Saxenda side effects
  • Took Saxenda by prescription to manage your weight
  • Weren’t warned about the risk of your injury before starting Saxenda

Developing a serious condition after taking Saxenda doesn’t automatically mean you qualify. Even so, it’s worth finding out if there’s a way to seek accountability and compensation.

Call (877) 640-6101 now to see if you’re eligible for a Saxenda side effects lawsuit.

Saxenda Lawsuit Updates and News

Federal Saxenda cases have been grouped into 2 multidistrict litigations (MDLs) in the U.S. District Court for the Eastern District of Pennsylvania. MDL 3094 handles stomach and bowel injury claims, while MDL 3163 handles NAION vision loss claims. Neither has reached settlements or verdicts as of October 2026.

Saxenda is one of several drugs named in weight loss drug lawsuits, along with Mounjaro®, Ozempic, and more. Following these cases can help you know what to expect.

Here are the latest Saxenda lawsuit updates:

  • October 1, 2026: The MDLs had 4,025 pending stomach injury cases and 247 pending NAION cases. These totals include claims involving several GLP-1 drugs.
  • July 2, 2026: The judge in MDL 3163 allowed early discovery, when both sides share evidence, on whether weight loss drugs can cause NAION and whether their warnings were adequate.
  • March 16, 2026: The court scheduled a Science Day, where both sides explained the medical research on GLP-1 drugs and NAION.
  • December 15, 2025: A federal panel created MDL 3163 for NAION claims involving Saxenda, Ozempic, Wegovy, and Trulicity®.
  • December 12, 2024: A federal panel added Saxenda to MDL 3094, the stomach injury MDL.

Don’t confuse these MDLs with Saxenda class action lawsuits. While both can help similar claims move through the legal system, class action lawsuits typically divide settlements equally among all parties. MDLs award compensation according to case-specific factors, including Saxenda side effects and related evidence.

There may still be time for you to file a Saxenda lawsuit. We’re here to help you figure out your options.

Saxenda Lawsuit Settlement Amounts

No Saxenda claim has settled or ended in a trial verdict as of October 2026. Neither MDL has moved past the pretrial stage, when judges decide key issues like which expert evidence can be used.

No one can promise a specific settlement amount. However, compensation in dangerous drug cases is usually based on the details of each person’s experience. If you’re eligible, our team can connect you with an experienced weight loss drug lawyer who can help you understand the potential value of your claim.

Get in touch with us today to learn more about how much you could potentially receive through a Saxenda lawsuit.

How Saxenda Lawsuit Compensation May Help

If a Saxenda lawsuit is successful, compensation may help you cover the costs of your injury and move forward.

Saxenda compensation could help pay for:

  • Emotional distress
  • Future medical care
  • Lost wages and earning ability
  • Medical bills
  • Pain and suffering
  • Reduced quality of life
  • Vision aids and assistive services
  • Other related expenses

Serious Saxenda side effects can affect your ability to work, drive, read, and care for your family. Exploring your legal options could help you understand if you’re eligible for a weight loss drug lawsuit settlement and how much it may include.

How to File a Lawsuit Against Saxenda

You may have grounds for a claim if you’ve experienced Saxenda side effects that left you with a serious health condition and you weren’t properly warned about the risks.

Here’s what the Saxenda lawsuit process usually looks like:

  1. Get a free case review: Share what happened after you took Saxenda. If you’re eligible, we’ll get you in touch with our partner law firm.
  2. Gather your evidence: Records like your medical files, pharmacy history, and eye exams can support your claim. Your Saxenda lawyer will help collect them and other evidence as needed.
  3. File your Saxenda lawsuit: Your weight loss drug attorney will submit your claim to the right court before your state’s deadline passes.
  4. Let your lawyer take the lead: They’ll do their best to negotiate a fair settlement and can take your case to trial if necessary.

If you choose to file a Saxenda claim, you’ll have support every step of the way. We’ll help you understand your options before connecting you with a trusted legal team that’s prepared to fight for you.

Start the process today with a free, no-obligation case review.

Get Help After Vision Loss From Saxenda

Saxenda was supposed to safely help you reach important health goals. If you experienced serious vision problems or other complications after taking the weight loss medication, you deserve the opportunity to understand what happened and whether you have legal options.

Her Case Matters can connect you with experienced attorneys handling GLP-1 vision-loss claims. The weight loss drug lawyers we partner with have recovered $1.6 billion to date for families harmed by dangerous medications.

Get a free case review now or call our team at (877) 640-6101 to see if you qualify for a Saxenda lawsuit.

Saxenda Lawsuit FAQs

Is Saxenda a high-risk medication?

No, Saxenda doesn’t have a high-risk classification, but it can come with serious risks that people should know about before taking it.

The weight loss medication carries a boxed warning because it caused thyroid tumors in studies of rats and mice, though it’s unknown whether it causes this type of cancer in people.

Saxenda side effects can also include pancreatitis, gallbladder disease, vision loss, and other serious conditions. People filing lawsuits allege that the drug caused one or more of those diagnoses, and they weren’t aware of the risks when they started Saxenda.

If you were diagnosed with a serious health problem after taking this medication, contact us today to find out if you may be eligible for a Saxenda lawsuit.

When will the Saxenda lawsuit be settled?

No one knows when or if the Saxenda claims will settle. In the NAION MDL, the judge encouraged the parties to finish briefing on key issues by around mid-2027.

If the MDLs don’t settle, they may go to trial and result in verdicts. The compensation from verdicts may be higher in some cases, depending on factors like the evidence presented.

How long do I have to file a Saxenda lawsuit?

The deadline to file your claim depends on the statute of limitations that applies to your Saxenda lawsuit. Where you live, when your injury occurred, and when you discovered its potential connection to Saxenda may affect your lawsuit’s filing timeline.

Some people have 2 to 3 years to file their claims, while others only have 1 year to meet with a lawyer and start their Saxenda lawsuit.

An experienced Saxenda attorney can determine how much time you may have to file. Get your free case review now to speak with our team about working with one in our network.

Written by: Her Case Matters

At HerCaseMatters, we believe women deserve to be heard — especially when it comes to their health and safety. Too often, harmful drugs, devices, and corporate wrongdoing impact women’s lives without proper warning, support, or accountability. We’re here to change that. We work with trusted legal partners who are deeply experienced in holding powerful companies accountable. But more than that, we’re here to remind women everywhere that their pain is real, their experiences matter, and they deserve justice.

Last modified:
  1. DailyMed. (n.d.). (February 25, 2026). Label: SAXENDA- liraglutide injection, solution. Retrieved from: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143.
  2. DailyMed. (n.d.). Highlights of prescribing information. Retrieved from: https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143&type=display.
  3. GovInfo. (December 15, 2025). Transfer order. Retrieved from: https://www.govinfo.gov/content/pkg/USCOURTS-jpml-1_25-F-03163/pdf/USCOURTS-jpml-1_25-F-03163-0.pdf.
  4. Lee, J. J., Brothers, T., Kim, L. A., et al. (September 3, 2026). Glucagon-like peptide-1 receptor agonist use and risk of nonarteritic anterior ischemic optic neuropathy in patients with type 2 diabetes. Retrieved from: https://www.sciencedirect.com/science/article/abs/pii/S2468653026004355?via%3Dihub.
  5. Mayo Clinic. (n.d.). Liraglutide (subcutaneous route). Retrieved from: https://www.mayoclinic.org/drugs-supplements/liraglutide-subcutaneous-route/description/drg-20073828.
  6. MedLibrary.org. (February 25, 2026). Saxenda (Page 3 of 10). Retrieved from: https://medlibrary.org/lib/rx/meds/saxenda-1/page/3/.
  7. MedlinePlus. (December 15, 2025). Liraglutide injection. Retrieved from: https://medlineplus.gov/druginfo/meds/a611003.html.
  8. North American Neuro-Ophthalmology Society. (n.d.). Non-arteritic anterior ischemic optic neuropathy. Retrieved from: https://www.nanosweb.org/naion/.
  9. Sokolove Law. (September 10, 2026). Saxenda® lawsuit. Retrieved from: https://www.sokolovelaw.com/dangerous-drugs/ozempic/saxenda/.
  10. United States District Court for the Eastern District of Pennsylvania. (July 2, 2026). Case management order no. 12. Retrieved from: https://www.paed.uscourts.gov/sites/paed/files/mdl-orders/25md3163_cm-ord_12.pdf.
  11. United States District Court for the Eastern District of Pennsylvania. (March 16, 2026). Case management order no. 6. Retrieved from: https://www.paed.uscourts.gov/sites/paed/files/mdl-orders/25md3163_cm-ord_6.pdf.
  12. United States Judicial Panel on Multidistrict Litigation. (December 12, 2024). Transfer order. Retrieved from: https://www.jpml.uscourts.gov/sites/jpml/files/MDL-3094-Transfer_Order-12-24.pdf.
  13. United States Judicial Panel on Multidistrict Litigation. (October 1, 2026). MDL statistics report – Distribution of pending MDL dockets by actions pending. Retrieved from: https://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_Actions_Pending-October-1-2026.pdf.
Get a Free Case Review